文献速递冠心病外科

冠状动脉瘤:外科治疗趋势的演变

Coronary artery aneurysms: Evolving trends in surgical management.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-09-25

回顾性分析2006年1月至2025年1月克利夫兰诊所146例(172个冠状动脉瘤)冠状动脉手术患者,分为动脉瘤为手术指征组(85例)与非指征组(61例),评估手术指征、术式趋势与结局;动脉瘤导向的复杂重建术式随时间增加,指征明确者修复不增加风险,远期生存与机构内年龄性别匹配的冠脉搭桥队列相似。

要点

  • 动脉瘤为指征者术式趋向更复杂的动脉瘤导向重建,包括移植血管重建。
  • 指征包括瘤体大小、动脉瘤相关心肌缺血、分流、合并冠心病及感染。
  • 指征明确者行外科修复未增加手术风险,远期生存与匹配冠脉搭桥队列相当。

核心结论

  • 冠状动脉瘤外科管理已向更复杂的动脉瘤导向重建演变。
  • 当有瘤体大小、缺血、分流、感染或症状指征时,外科修复可在不增加风险的情况下完成。
  • 两组的远期生存与机构内年龄、性别匹配的冠状动脉搭桥队列相似(指征组log-rank P = .67;非指征组log-rank P = .45)。

研究设计与样本

  • 回顾性分析2006年1月至2025年1月克利夫兰诊所146例冠状动脉瘤患者(年龄63 ± 13岁;37例[25%]女性),共172个冠状动脉瘤。
  • 按动脉瘤是否为手术直接或间接指征分为指征组(N = 85)与非指征组(N = 61),分析指征、手术趋势与结局。

主要发现

  • 指征组手术指征包括瘤体大小(58例[68%])、动脉瘤相关冠状动脉缺血(55例[65%])、分流(27例[32%])、合并冠状动脉疾病(22例[26%])和感染(4例[4.7%])。
  • 非指征组唯一指征为冠状动脉疾病所致心肌缺血。
  • 指征组术式包括冠状动脉旁路移植(60例[71%])、单纯冠状动脉旁路移植(14例[16%])、切除/结扎(34例[40%])、瘘管结扎(31例[36%])、原位移植血管重建(19例[22%])及直接修复(9例[11%])。
  • 非指征组全部仅行冠状动脉旁路移植。
  • 指征组与非指征组手术死亡率分别为2.4%与3.4%;5年与10年生存率指征组为80%与63%,非指征组为63%与48%。

关键数值与推荐

  • 指征组中瘤体大小作为手术指征者58例(68%),动脉瘤相关冠状动脉缺血55例(65%),分流27例(32%),合并冠状动脉疾病22例(26%),感染4例(4.7%)。
  • 指征组接受冠状动脉旁路移植60例(71%),其中单纯旁路移植14例(16%);切除/结扎34例(40%);瘘管结扎31例(36%);原位移植血管重建19例(22%);直接修复9例(11%)。
  • 手术死亡率指征组2.4%、非指征组3.4%;5年与10年生存率指征组80%与63%,非指征组63%与48%。
  • 与机构内年龄、性别匹配的冠状动脉搭桥队列比较,指征组log-rank P = .67,非指征组log-rank P = .45。

临床怎么用

  • 对因瘤体大小、缺血、分流、感染或症状而有指征的冠状动脉瘤,可考虑外科修复,未观察到手术风险增加。
  • 术式选择可包括冠状动脉旁路移植、切除/结扎、瘘管结扎、移植血管重建或直接修复,并随时间趋向更复杂的动脉瘤导向重建。
  • 无动脉瘤相关指征者仅行冠状动脉旁路移植即可,其远期生存与匹配搭桥队列相似。

局限性

  • 本文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate temporal trends and evolution of surgical techniques for coronary artery aneurysms. METHODS: From January 2006 to January 2025, 146 patients (age 63 ± 13 years; 37 [25%] female) with 172 coronary aneurysms underwent coronary surgery at Cleveland Clinic. Indications, operative trends, and outcomes were analyzed. Patients were divided into 2 groups: the addressed (N = 85), when the aneurysm was a direct or indirect indication for surgery, and the unaddressed (N = 61), when it was not. RESULTS: Operative indications in the addressed group were size (58 [68%]), aneurysm-related coronary ischemia (55 [65%]), shunting (27 [32%]), concomitant coronary artery disease (22 [26%]), and infection (4 [4.7%]). In the unaddressed group, coronary ischemia due to coronary artery disease was the sole indication. Patients in the addressed group underwent 1 or more of the following: coronary artery bypass grafting (60 [71%]), (14 [16%] coronary artery bypass grafting alone), excision/ligation (34 [40%]), fistula ligation (31 [36%]), in situ graft-based reconstruction (19 [22%]), and direct repair (9 [11%]). More comprehensive aneurysm-directed repairs, including graft-based reconstruction, increased over time. All unaddressed patients underwent coronary artery bypass grafting alone. Operative mortality was 2.4% and 3.4% for the addressed and unaddressed groups, respectively. Five- and 10-year survivals were 80% and 63% in the addressed group and 63% and 48% in the unaddressed group, respectively. Survival in both groups was similar to our institutional age- and sex-matched coronary artery bypass grafting cohorts (addressed log-rank P = .67; unaddressed log-rank P = .45). CONCLUSIONS: Surgical management of coronary artery aneurysms has evolved toward more complex aneurysm-directed reconstructions. When indicated by aneurysm size, ischemia, shunting, infection, or symptoms, surgical repair can be performed without added risk, with long-term survival comparable to that of the general population undergoing coronary artery bypass grafting.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Alshneikat M, Alaraj R, Awad AK, et al. Coronary artery aneurysms: Evolving trends in surgical management. J Thorac Cardiovasc Surg. 2026. PMID: 42790621. doi:10.1016/j.jtcvs.2026.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。